Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emily Ariail

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Immunological Investigations|February 21, 2025
IL-7 Immunotherapies: Current Applications and Engineering OpportunitiesEmily Ariail, Benjamin Biggs, Rowan O'Flanagan, et al.
Cell Systems|December 19, 2024
Emerging approaches for T cell-stimulating platform developmentEmily Ariail, Nikol Garcia Espinoza, A Carson Stephenson, et al.
Frontiers in Immunology|March 25, 2026
Miniaturized IL-2/anti-IL-2 immunocytokines selectively activate and support the <i>in vivo</i> persistence of regulatory T cellsCharina S Fabilane, Jakub Tomala, Paul M Zdinak, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 6, 2023
Oncolytic α-herpesvirus and myeloid-tropic cytomegalovirus cooperatively enhance systemic antitumor responsesHaifei Jiang, Rebecca Nace, Emily Ariail, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 27, 2025
Bispecific receptor decoy proteins block ocular neovascularization via simultaneous blockade of vascular endothelial growth factor A and CPaul R Sargunas, Emily Ariail, Raquel Lima E Silva, et al.
Science Advances|December 13, 2024
Ex vivo expansion and hydrogel-mediated in vivo delivery of tissue-resident memory T cells for immunotherapyShuyi Li, Zhi-Cheng Yao, Hanzhi Wang, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Immunological Investigations|February 21, 2025
IL-7 Immunotherapies: Current Applications and Engineering OpportunitiesEmily Ariail, Benjamin Biggs, Rowan O'Flanagan, et al.
Cell Systems|December 19, 2024
Emerging approaches for T cell-stimulating platform developmentEmily Ariail, Nikol Garcia Espinoza, A Carson Stephenson, et al.
Frontiers in Immunology|March 25, 2026
Miniaturized IL-2/anti-IL-2 immunocytokines selectively activate and support the <i>in vivo</i> persistence of regulatory T cellsCharina S Fabilane, Jakub Tomala, Paul M Zdinak, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 6, 2023
Oncolytic α-herpesvirus and myeloid-tropic cytomegalovirus cooperatively enhance systemic antitumor responsesHaifei Jiang, Rebecca Nace, Emily Ariail, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 27, 2025
Bispecific receptor decoy proteins block ocular neovascularization via simultaneous blockade of vascular endothelial growth factor A and CPaul R Sargunas, Emily Ariail, Raquel Lima E Silva, et al.
Science Advances|December 13, 2024
Ex vivo expansion and hydrogel-mediated in vivo delivery of tissue-resident memory T cells for immunotherapyShuyi Li, Zhi-Cheng Yao, Hanzhi Wang, et al.
Pageof 1